Breaking News Bar
updated: 9/5/2013 10:09 AM

FDA approves French plant's manufacture of Horizon Pharma drug

Success - Article sent! close

DEERFIELD -- The U.S. Food and Drug Administration has approved Horizon Pharma's use of Sanofi's manufacturing site in Compiègne, France to manufacture the rheumatoid arthritis drug Duexis.

"We have had a successful long-term partnership with Sanofi and are pleased with the FDA's approval of the Compiègne site as an additional manufacturing facility for Duexis," said Hans-Peter Zobel, Ph.D., senior vice president, manufacturing, Horizon Pharma. "This approval provides us a quality backup manufacturing site, enhancing our ability to ensure an adequate long-term supply of Duexis."

Valiant Pharmaceuticals' manufacturing site in Laval, Quebec, previously owned and operated by Sanofi, serves as the primary commercial manufacturing site for Duexis.

Article Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.